Klingenstein Fields & CO LP Pfizer Inc Transaction History

Klingenstein Fields & CO LP

$2.48 Billion
Q3 2024

A detailed history of Klingenstein Fields & CO LP transactions in Pfizer Inc stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 17,262 shares of PFE stock, worth $461,585. This represents 0.02% of its overall portfolio holdings.

Number of Shares

17,262

Previous 348,187 95.04%

Holding current value

$461,585

Previous $9.74 Million 94.88%

% of portfolio

0.02%

Previous 0.41%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$27.7 - $31.39 $9.17 Million - $10.4 Million	-330,925 Reduced 95.04%	17,262 $499,000
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $164,973 - $193,317	-6,531 Reduced 1.84%	348,187 $9.74 Million
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $843,444 - $968,543	32,578 Added 10.11%	354,718 $9.84 Million
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $244,054 - $316,999	-9,340 Reduced 2.82%	322,140 $9.27 Million
Q3 2023 Oct 27, 2023	BUY	$32.09 - $37.51 $270,422 - $316,096	8,427 Added 2.61%	331,480 $11 Million
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $184,031 - $212,920	-5,095 Reduced 1.55%	323,053 $11.8 Million
Q1 2023 Apr 28, 2023	BUY	$39.39 - $51.28 $31,275 - $40,716	794 Added 0.24%	328,148 $13.4 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $312,582 - $408,041	-7,487 Reduced 2.24%	327,354 $16.8 Million
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $938,476 - $1.15 Million	21,446 Added 6.84%	334,841 $14.7 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $88,639 - $105,098	1,905 Added 0.61%	313,395 $16.4 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $179,614 - $222,564	-3,926 Reduced 1.24%	311,490 $16.1 Million
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $30,080 - $44,590	-728 Reduced 0.23%	315,416 $18.6 Million
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $4.37 Million - $5.62 Million	-111,400 Reduced 26.06%	316,144 $13.6 Million
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $502,165 - $568,869	13,984 Added 3.38%	427,544 $16.7 Million
Q1 2021 Apr 29, 2021	BUY	$33.49 - $37.77 $430,848 - $485,911	12,865 Added 3.21%	413,560 $15 Million
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $331,051 - $420,960	9,891 Added 2.53%	400,695 $14.7 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $238,696 - $280,045	7,518 Added 1.96%	390,804 $14.3 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $348,036 - $422,219	11,555 Added 3.11%	383,286 $12.5 Million
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $776,652 - $1.11 Million	28,733 Added 8.38%	371,731 $12.1 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $372,819 - $423,102	-11,325 Reduced 3.2%	342,998 $13.4 Million
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $91,231 - $118,301	2,808 Added 0.8%	354,323 $12.7 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $444,203 - $498,738	12,012 Added 3.54%	351,515 $15.2 Million
Q1 2019 Apr 29, 2019	BUY	$37.5 - $41.2 $478,350 - $525,547	12,756 Added 3.9%	339,503 $14.4 Million
Q4 2018 Jan 22, 2019	BUY	$38.47 - $43.86 $213,085 - $242,940	5,539 Added 1.72%	326,747 $14.3 Million
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $319,778 - $387,871	-9,277 Reduced 2.81%	321,208 $14.2 Million
Q2 2018 Jul 26, 2018	BUY	$32.98 - $35.16 $164,009 - $174,850	4,973 Added 1.53%	330,485 $12 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $416,585 - $483,296	13,055 Added 4.18%	325,512 $11.6 Million
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $73,471 - $77,955	2,209 Added 0.71%	312,457 $11.3 Million
Q3 2017 Nov 01, 2017	BUY	$31.0 - $34.15 $9.62 Million - $10.6 Million	310,248	310,248 $11.1 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Account

Klingenstein Fields & CO LP Pfizer Inc Transaction History